| scholarly article | Q13442814 |
| P356 | DOI | 10.1034/J.1399-0012.1999.130410.X |
| P698 | PubMed publication ID | 10485376 |
| P2093 | author name string | Cosio FG | |
| Falkenhain ME | |||
| Ferguson RM | |||
| Henry ML | |||
| Pesavento TE | |||
| Yim S | |||
| Alamir A | |||
| P2860 | cites work | International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology | Q34354852 |
| The human costs of tobacco use (1) | Q40717928 | ||
| Cardiac and cerebrovascular disease in chronic uremia | Q40868227 | ||
| Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention | Q40949366 | ||
| Hyperlipidemia in solid organ transplantation. | Q41353423 | ||
| Relationships between arterial hypertension and renal allograft survival in African-American patients. | Q44228024 | ||
| Racial differences in renal allograft survival: the role of systemic hypertension. | Q46740685 | ||
| Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. | Q50614527 | ||
| Increased Prevalence of Dysplastic and Malignant Lip Lesions in Renal-Transplant Recipients | Q57168859 | ||
| Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study | Q68679742 | ||
| Management of the diabetic transplant recipient | Q70847592 | ||
| Cigarette smoking: an epidemiological overview | Q71362619 | ||
| De novo solid malignancies after cardiac transplantation | Q71487413 | ||
| Hyperlipidemia in renal transplant recipients: natural history and response to treatment | Q72084012 | ||
| Cardiac function and hematocrit level | Q72123075 | ||
| Renal transplantation in older people | Q72667724 | ||
| Patient survival after renal transplantation: I. The impact of dialysis pre-transplant | Q74326609 | ||
| P433 | issue | 4 | |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 336-341 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Clinical Transplantation | Q15754920 |
| P1476 | title | Patient survival after renal transplantation: II. The impact of smoking. | |
| P478 | volume | 13 |
| Q34337063 | 2,500 living donor kidney transplants: a single-center experience |
| Q36758702 | A randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke: study protocol for a randomized controlled trial |
| Q39445425 | Abdominal Organ Transplant Center Tobacco Use Policies Vary by Organ Program Type |
| Q38459121 | Assessing pharmacologic and nonpharmacologic risks in candidates for kidney transplantation |
| Q40485517 | Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up |
| Q38235860 | Cardiovascular morbidity and mortality after kidney transplantation |
| Q35757120 | Chronic allograft nephropathy: causes of death and mortality risk factors-a review of the last decade in Spain |
| Q40088806 | Cigarette Smoking and Its Hazards in Kidney Transplantation |
| Q37967043 | Cigarette smoking and chronic kidney diseases |
| Q84664396 | Cigarette smoking and second-hand smoking exposure in adolescents with chronic kidney disease: a study from the Midwest Pediatric Nephrology Consortium |
| Q36760536 | Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insights |
| Q57653070 | Cigarette smoking in living kidney donors: donor and recipient outcomes |
| Q37165278 | Cigarette smoking: an important renal risk factor - far beyond carcinogenesis |
| Q46661747 | Cigarette smoking: an important renal risk factor – far beyond carcinogenesis. |
| Q36085210 | Differential impact of smoking on mortality and kidney transplantation among adult Men and Women undergoing dialysis |
| Q38333397 | Donor Smoking Negatively Affects Donor and Recipient Renal Function following Living Donor Nephrectomy |
| Q37218152 | Ethical analysis and consideration of health behaviors in organ allocation: focus on tobacco use. |
| Q46884909 | Impact of Substance Abuse on Access to Renal Transplantation |
| Q38798599 | Impact of environmental factors on alloimmunity and transplant fate |
| Q80149749 | Living-donor kidney transplantation: the Freiburg experience |
| Q79815464 | Long-term graft and patient survival following renal transplantation in diabetic patients |
| Q37089454 | Management of cardiovascular disease in renal transplant recipients |
| Q36010496 | Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts |
| Q36635470 | Post-transplant diabetes mellitus: risk reduction strategies in the elderly |
| Q37779718 | Pretransplant cardiovascular evaluation and posttransplant cardiovascular risk |
| Q46427162 | Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with athero-thrombosis risk markers |
| Q82888149 | Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients |
| Q64898767 | Should donors who have used marijuana be considered candidates for living kidney donation? |
| Q54211998 | Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial. |
| Q33617398 | Smoking in Renal Transplantation; Facts Beyond Myth |
| Q35632781 | Strategies for ensuring effective surveillance in post-transplant patients: practical organization and clinical evaluation |
| Q36469067 | Treating tobacco use and dependence in kidney transplant recipients: development and implementation of a program |
| Q36152820 | Use of the 'Accountability for Reasonableness' Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country |
| Q26771400 | Vascular calcification, bone and mineral metabolism after kidney transplantation |
Search more.